Workshop icsb: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 18: Line 18:
          
          
[[Workshop_icsb:Help | <font style="color:brown"> '''Contact''' </font>]]  
[[Workshop_icsb:Help | <font style="color:brown"> '''Contact''' </font>]]  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<!-- Feel free to add or remove items from the navigation bar to customize the header for your class. -->
<!-- Feel free to add or remove items from the navigation bar to customize the header for your class. -->



Revision as of 05:57, 15 July 2009

Disease Modeling and Simulation Workshop

September 3, 2009,   13:30 - 18:00hrs

Home            Schedule            Contact

Description

In the past year, numerous success cases on the topic have been reported, industrial/academic alliances have been formed, and industrial investments have increased. The goal of the workshop is to further collaboration and education in the utilization of systems biology in treating diseases in metabolism, oncology, immunity and infection. This workshop thus provides a venue for the participants to present and discuss systems biology applications in disease modeling and simulation for elucidating the mechanisms and controls in disease manifestation for better treatment decisions. Additional speakers who are active participants in the practice will be invited to share the techniques, successes and considerations in disease modeling and simulation. A panel discussion will be organized for additional discussion.

The topics include, but not limited to: (can be added or deleted based on the presenters’ topics)

  1. Mathematical modeling of diseases and disease progression
  2. Model-aided approach to disease treatment, including identification of drug targets, drug dosage design, drug cocktail
  3. Challenges and future directions in the systems biology of diseases

Intended Audience

Participants who are interested in learning how systems biology methods are applied in disease treatment, and in discussing challenges and future of disease modeling and simulation